Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Even After Patent Cliff, Pfizer Is Undervalued
Even After Patent Cliff, Pfizer Is Undervalued
Even After Patent Cliff, Pfizer Is Undervalued
Submitted by
admin
on July 29, 2010 - 10:48am
Source:
Yahoo/Morningstar
News Tags:
Pfizer
patents
Headline:
Even After Patent Cliff, Pfizer Is Undervalued
Do Not Allow Advertisers to Use My Personal information
